BDBM437081 1-[2-(3,3-Difluoroazetidin-1-yl)-2-oxo-ethyl]-6-(2-fluoro-3-methyl-phenyl)-3- methyl-imidazo[4,5-b]pyridin-2-one::US10617676, Example 418::US11207298, Example 418

SMILES Cc1cccc(-c2cnc3n(C)c(=O)n(CC(=O)N4CC(F)(F)C4)c3c2)c1F

InChI Key InChIKey=JUTPYHATFOVNMC-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 437081   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM437081(US10617676, Example 418 | 1-[2-(3,3-Difluoroazetid...)
Affinity DataIC50: 19nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
US Patent

TargetGlutamate receptor ionotropic, NMDA 1/2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM437081(US10617676, Example 418 | 1-[2-(3,3-Difluoroazetid...)
Affinity DataIC50: 19nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
US Patent